JACKIE SEE
Medical Practice in Las Vegas, NV
License number
Alaska MEDS1521
Issued Date
Aug 3, 1978
Effective Date
Dec 31, 1990
Expiration Date
Dec 31, 1992
Category
Medical
Address
Address
PO Box 15645, Las Vegas, NV 89114
Professional information
Pge-1 Containing Lyophilized Liposomes For Use In The Treatment Of Erectile Dysfunction
US Patent:
5718917, Feb 17, 1998
Filed:
Dec 15, 1995
Appl. No.:
8/573408
Inventors:
Jackie R. See - Las Vegas NV
Assignee:
Harvard Scientific Corporation - Reno NV
International Classification:
A61K 9127
US Classification:
424450
Abstract:
A method for the treatment of erectile dysfunction comprises instilling intra meatally an aqueous solution containing prostaglandin-containing liposomes and a detergent for lysing the liposomes. A pharmaceutical composition for treating erectile dysfunction comprises a two-component system. The first component comprises a predetermined amount of lyophilized prostaglandin-containing liposomes. The second component comprises a predetermined volume of an aqueous solution containing a detergent, preferably PEG(9) octylphenyl ether, for lysing the liposomes. Dissolution of the lyophilized prostaglandin-containing liposomes yields a liquid composition suitable for application to the penis, preferably intra meatally, to effect erection.
Composition And Method For Making A Biodegradable Drug Delivery Stent
US Patent:
5980551, Nov 9, 1999
Filed:
Feb 7, 1997
Appl. No.:
8/797743
Inventors:
David P. Summers - Montgomery TX
Jackie R. See - Las Vegas NV
Jackie R. See - Las Vegas NV
Assignee:
Endovasc Ltd., Inc. - Montgomery TX
International Classification:
A61M 2900
US Classification:
606194
Abstract:
A stent or vascular graft for supporting a blood vessel or organ lumen is coated with a biodegradable, resorbable and hemocompatible surface substrate. Biologically active microspheres which controllably release the biologically active agent into the vessel wall or organ to inhibit restenosis of the stent is embedded in the stent substrate. The biologically active microspheres include encapsulated PGE1 in a water soluble polyethylene glycol mix, which over a period of time dissolves and releases the PGE1 into the vessel wall or organ.